$ILLR
Triller Group Inc. Stock $illr

$illr Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024027225 Filed on March 28, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$7.656M	$12.54M	$54.19M
YoY Change	-30.86%	-59.66%	74.35%
Cost Of Revenue	$4.446M	$9.092M	$37.29M
YoY Change	-39.05%	-51.7%	98.09%
Gross Profit	$3.210M	$3.446M	$16.90M
YoY Change	-15.04%	-71.88%	37.9%
Gross Profit Margin	41.93%	27.49%	31.19%
Selling, General & Admin	$10.86M	$10.99M	$59.96M
YoY Change	40.87%	-72.83%	246.01%
% of Gross Profit	338.46%	318.99%	354.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$22.88K	$21.32K	$261.3K
YoY Change	-77.39%	-94.57%	-33.48%
% of Gross Profit	0.71%	0.62%	1.55%
Operating Expenses	$15.52M	$10.99M	$59.96M
YoY Change	-39.52%	-72.83%	0.89%
Operating Profit	-$7.862M	-$7.547M	-$43.06M
YoY Change	-46.09%	-73.25%	51.88%
Interest Expense	$207.2K	-$6.479M	-$6.370M
YoY Change	25.52%	-44.25%	-4629.45%
% of Operating Profit
Other Income/Expense, Net	-$160.8K	-$34.68K	$225.8K
YoY Change	-106.47%	-99.24%	-101.41%
Pretax Income	-$8.023M	-$13.40M	-$48.92M
YoY Change	-33.69%	-69.83%	10.19%
Income Tax	$37.52K	$230.9K	$286.5K
% Of Pretax Income
Net Earnings	-$8.060M	-$13.63M	-$49.21M
YoY Change	-33.24%	-69.39%	10.52%
Net Earnings / Revenue	-105.28%	-108.69%	-90.8%
Basic Earnings Per Share	-$0.11		-$0.75
Diluted Earnings Per Share	-$0.11	-$0.20	-$0.75
COMMON SHARES
Basic Shares Outstanding	74.39M shares	67.56M shares	65.27M shares
Diluted Shares Outstanding	70.11M shares		65.27M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.140M	$1.861M	$1.861M
YoY Change	-41.44%	-79.07%	-71.14%
Cash & Equivalents	$2.139M	$1.861M	$1.861M
Short-Term Investments	$966.00	$595.00
Other Short-Term Assets	$17.36M	$18.59M	$18.59M
YoY Change	-62.32%	-59.09%	-59.09%
Inventory
Prepaid Expenses
Receivables	$1.750M	$4.065M	$4.065M
Other Receivables	$960.4K	$1.106M	$1.106M
Total Short-Term Assets	$23.11M	$25.62M	$25.62M
YoY Change	-57.4%	-54.05%	-54.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.695M	$13.23M	$13.23M
YoY Change	-76.53%	79.76%	79.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$23.25M	$25.72M	$25.72M
YoY Change	-32.7%	-30.54%	-30.54%
Other Assets	$964.7K	$961.3K	$961.3K
YoY Change
Total Long-Term Assets	$38.01M	$40.97M	$40.97M
YoY Change	-12.46%	-9.89%	-9.89%
TOTAL ASSETS
Total Short-Term Assets	$23.11M	$25.62M	$25.62M
Total Long-Term Assets	$38.01M	$40.97M	$40.97M
Total Assets	$61.12M	$66.59M	$66.59M
YoY Change	-37.42%	-34.21%	-34.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.90M	$19.75M	$19.75M
YoY Change	2.26%	-2.57%	-2.57%
Accrued Expenses	$1.247M	$1.229M	$1.229M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$1.791M	$6.805M	$6.805M
YoY Change	-71.35%	51.99%	51.99%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$48.07M	$47.84M	$47.84M
YoY Change	-49.28%	-50.69%	-50.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$10.31M	$10.65M	$10.65M
YoY Change	266179.07%	233879.12%	233879.12%
Total Long-Term Liabilities	$10.30M	$10.65M	$10.65M
YoY Change	20726.17%	21020.6%	233879.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$48.07M	$47.84M	$47.84M
Total Long-Term Liabilities	$10.30M	$10.65M	$10.65M
Total Liabilities	$58.37M	$58.49M	$58.49M
YoY Change	-38.43%	-39.75%	-39.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$73.66M	-$65.60M
YoY Change	43.12%	66.52%
Common Stock	$76.68M	$74.17M
YoY Change	124079.25%	126957.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.744M	$8.103M	$8.103M
YoY Change
Total Liabilities & Shareholders Equity	$61.12M	$66.59M	$66.59M
YoY Change	-37.42%	-34.21%	-34.21%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$8.060M	-$13.63M	-$49.21M
YoY Change	-33.24%	-69.39%	10.52%
Depreciation, Depletion And Amortization	$22.88K	$21.32K	$261.3K
YoY Change	-77.39%	-94.57%	-33.48%
Cash From Operating Activities	-$6.857M	-$8.922M	-$42.28M
YoY Change	-32.75%	-51.89%	119.03%
INVESTING ACTIVITIES
Capital Expenditures		$4.850K	$104.9K
YoY Change		-99.5%	-89.17%
Acquisitions
YoY Change
Other Investing Activities	$2.168M	$6.107M	$10.90M
YoY Change	-45.67%	-146.19%	-182.42%
Cash From Investing Activities	$2.168M	$6.102M	$10.79M
YoY Change	-45.67%	-143.0%	-176.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.850M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.500M	-629.9K	-1.040M
YoY Change	0.95%	-105.5%	-108.57%
NET CHANGE
Cash From Operating Activities	-$6.857M	-8.922M	-42.28M
Cash From Investing Activities	$2.168M	6.102M	10.79M
Cash From Financing Activities	$3.500M	-629.9K	-1.040M
Net Change In Cash	-$950.1K	-3.450M	-32.53M
YoY Change	-64.26%	-83.79%	49.31%
FREE CASH FLOW
Cash From Operating Activities	-$6.857M	-$8.922M	-$42.28M
Capital Expenditures		$4.850K	$104.9K
Free Cash Flow		-$8.927M	-$42.39M
YoY Change		-54.25%	109.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent		usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2023Q4	agba	Forward Share Purchase Liability Current ForwardSharePurchaseLiabilityCurrent		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38909
CY2023	dei	Entity Registrant Name EntityRegistrantName	AGBA GROUP HOLDING LIMITED
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D8
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	AGBA Tower
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	68 Johnston Road
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Wan Chai
CY2023	dei	Entity Address Country EntityAddressCountry	HK
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	N/A
CY2023	dei	City Area Code CityAreaCode	+852
CY2023	dei	Local Phone Number LocalPhoneNumber	3601 8000
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	13594412	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	74391357	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	WWC, P.C
CY2023	dei	Auditor Firm AuditorFirmId	1171
CY2023	dei	Auditor Location AuditorLocation	San Mateo, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1861223	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6449876	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	16816842	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	44844196	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2970636	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2822162	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	549461	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	517479	usd
CY2023Q4	agba	Notes Receivable Net Current NotesReceivableNetCurrent	557003	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	260120	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1769582	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	589786	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	25618972	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	55756165	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	961253	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1054841	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1072392	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1721284	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7359416	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11508153	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	25201933	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	36510803	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	40969995	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	45465168	usd
CY2023Q4	us-gaap	Assets Assets	66588967	usd
CY2022Q4	us-gaap	Assets Assets	101221333	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	19754041	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	20274429	usd
CY2023Q4	agba	Escrow Liabilities Current EscrowLiabilitiesCurrent	16816842	usd
CY2022Q4	agba	Escrow Liabilities Current EscrowLiabilitiesCurrent	29487616	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1804950	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	4477254	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2906261	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6289743	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	328720	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1229329	usd
CY2022Q4	agba	Forward Share Purchase Liability Current ForwardSharePurchaseLiabilityCurrent	13491606	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	47840143	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	74020648	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10646053	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4548	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	45858	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10646053	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	50406	usd
CY2023Q4	us-gaap	Liabilities Liabilities	58486196	usd
CY2022Q4	us-gaap	Liabilities Liabilities	74071054	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68661998	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68661998	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58376985	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58376985	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	68662	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	58377	usd
CY2023Q4	agba	Ordinary Shares To Be Issued OrdinarySharesToBeIssued	4854	usd
CY2022Q4	agba	Ordinary Shares To Be Issued OrdinarySharesToBeIssued	1665	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	74103494	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	43870308	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-473087	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-384938	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65601152	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16395133	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8102771	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27150279	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	66588967	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	101221333	usd
CY2023	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	157190	usd
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	176175	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	157190	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	176175	usd
CY2023	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	50068936	usd
CY2022	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	26561691	usd
CY2023	us-gaap	Noninterest Income Other NoninterestIncomeOther	2992918	usd
CY2022	us-gaap	Noninterest Income Other NoninterestIncomeOther	3372449	usd
CY2023	agba	Recurring Asset Management Service Fees Related Party RecurringAssetManagementServiceFeesRelatedParty	970143	usd
CY2022	agba	Recurring Asset Management Service Fees Related Party RecurringAssetManagementServiceFeesRelatedParty	969912	usd
CY2023	us-gaap	Noninterest Income NoninterestIncome	54031997	usd
CY2022	us-gaap	Noninterest Income NoninterestIncome	30904052	usd
CY2023	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	54189187	usd
CY2022	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	31080227	usd
CY2023	us-gaap	Interest Expense InterestExpense	784479	usd
CY2022	us-gaap	Interest Expense InterestExpense	140644	usd
CY2023	us-gaap	Noninterest Expense Commission Expense NoninterestExpenseCommissionExpense	37287519	usd
CY2022	us-gaap	Noninterest Expense Commission Expense NoninterestExpenseCommissionExpense	18823458	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3708557	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11141672	usd
CY2023	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	4557196	usd
CY2022	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1209035	usd
CY2023	agba	Personnel And Benefit Expense PersonnelAndBenefitExpense	27217822	usd
CY2022	agba	Personnel And Benefit Expense PersonnelAndBenefitExpense	21928504	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	13601274	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1265866	usd
CY2023	agba	Legal And Professional Fees Related Party LegalAndProfessionalFeesRelatedParty	333332	usd
CY2023	agba	Allowance For Expected Credit Losses On Financial Instruments AllowanceForExpectedCreditLossesOnFinancialInstruments	1077184	usd
CY2022	agba	Allowance For Expected Credit Losses On Financial Instruments AllowanceForExpectedCreditLossesOnFinancialInstruments	16509	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	9467146	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	4905636	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	98034509	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	59431324	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-43845322	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-28351097	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	383720	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	99132	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	909227	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2643261	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-6878869	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-8937431	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4548	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8952	usd
CY2023	agba	Change In Fair Value Of Forward Share Purchase Liability ChangeInFairValueOfForwardSharePurchaseLiability	82182	usd
CY2022	agba	Change In Fair Value Of Forward Share Purchase Liability ChangeInFairValueOfForwardSharePurchaseLiability	5392293	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-378895	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	664816	usd
CY2023	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	239239	usd
CY2022	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	315233	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	64237	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	504735	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5074159	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16044933	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-48919481	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-44396030	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	286538	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	124605	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-49206019	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-44520635	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	88149	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	205477	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-49294168	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-44726112	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65265397	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56084858	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.79
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	61145572	usd
CY2022	agba	Stock Issued During Period Value Restatement StockIssuedDuringPeriodValueRestatement	23000000	usd
CY2021Q4	agba	Stockholders Equity Restatement StockholdersEquityRestatement	84145572	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	7203070	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-8308754	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	6284896	usd
CY2022	agba	Stock Issued During Period Value Special Dividend To The Holding Company StockIssuedDuringPeriodValueSpecialDividendToTheHoldingCompany	-17437805	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2088725	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	8099313	usd
CY2022	agba	Adjustments To Additional Paid In Capital Forgiveness Of Amounts Due To The Holding Company AdjustmentsToAdditionalPaidInCapitalForgivenessOfAmountsDueToTheHoldingCompany	6000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-44520635	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-205477	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27150279	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4000000	usd
CY2023	agba	Stock Issued During Period Value Issuance Of Ordinary Shares For Private Placement StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesForPrivatePlacement	1850310	usd
CY2023	agba	Stock Issued During Period Value Issuance Of Ordinary Shares For Commitment Fee StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesForCommitmentFee	276000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11526966	usd
CY2023	agba	Stock Issued During Period Value Forgiveness Of Amounts Due To The Holding Company StockIssuedDuringPeriodValueForgivenessOfAmountsDueToTheHoldingCompany	12593384	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-88149	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-49206019	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8102771	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-49206019	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-44520635	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	11235026	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2088725	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	1496286	usd
CY2023	us-gaap	Depreciation Depreciation	261323	usd
CY2022	us-gaap	Depreciation Depreciation	392873	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	34665	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	784479	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	909227	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2643261	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-6878869	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-8937431	usd
CY2023	agba	Allowance For Expected Credit Losses On Financial Instruments AllowanceForExpectedCreditLossesOnFinancialInstruments	1077184	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4548	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8952	usd
CY2023	agba	Change In Fair Value Of Forward Shares Purchase Liability ChangeInFairValueOfForwardSharesPurchaseLiability	82182	usd
CY2022	agba	Change In Fair Value Of Forward Shares Purchase Liability ChangeInFairValueOfForwardSharesPurchaseLiability	5392293	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	664816	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-378895	usd
CY2023	agba	Reversal Of Annual Bonus Accrued In Prior Year ReversalOfAnnualBonusAccruedInPriorYear	3595028	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1187628	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1947089	usd
CY2023	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	15656	usd
CY2022	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	-2319054	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	2495082	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	198512	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6894066	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10877792	usd
CY2023	agba	Increase Decreasein Escrow Liabilities IncreaseDecreaseinEscrowLiabilities	-12670774	usd
CY2022	agba	Increase Decreasein Escrow Liabilities IncreaseDecreaseinEscrowLiabilities	-4998181	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1130008	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	542982	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-282459	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-42282159	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19304399	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	3976657	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	1853473	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	589086	usd
CY2023	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	288581	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	16228690	usd
CY2023	agba	Proceeds From Dividends Received From Longterm Investments ProceedsFromDividendsReceivedFromLongtermInvestments	1670045	usd
CY2022	agba	Proceeds From Dividends Received From Longterm Investments ProceedsFromDividendsReceivedFromLongtermInvestments	1154749	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6127576	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	104846	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	968367	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	10791765	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14188835	usd
CY2023	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	9342972	usd
CY2022	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	9752275	usd
CY2023	agba	Payment To Settlement Of Forward Share Purchase Agreement PaymentToSettlementOfForwardSharePurchaseAgreement	13952683	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	7746414	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	4464391	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	6026937	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1850310	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	17437805	usd
CY2022	agba	Cash Proceeds From Reverse Recapitalization Net Of Redemption CashProceedsFromReverseRecapitalizationNetOfRedemption	15356580	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1039924	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12135441	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-85689	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-429542	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-32616007	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21787335	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51294072	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73081407	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18678065	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51294072	usd
CY2023	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	427363	usd
CY2022	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	125353	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	172334	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	531592	usd
CY2023	agba	Cash Received From Interest CashReceivedFromInterest	349055	usd
CY2022	agba	Cash Received From Interest CashReceivedFromInterest	99132	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	784479	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	12512585	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	140644	usd
CY2023	agba	Forgiveness Of Amount Due To Shareholder ForgivenessOfAmountDueToShareholder	12593384	usd
CY2022	agba	Forgiveness Of Amount Due To Shareholder ForgivenessOfAmountDueToShareholder	6000000	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	4000000	usd
CY2022	agba	Issue Of Ordinary Shares To Settle Payables IssueOfOrdinarySharesToSettlePayables	7203070	usd
CY2022	agba	Purchase Of Property And Equipment Through Earnest Deposit PurchaseOfPropertyAndEquipmentThroughEarnestDeposit	7182131	usd
CY2022	agba	Special Dividend To The Shareholder Offset With Amount Due From The Shareholder SpecialDividendToTheShareholderOffsetWithAmountDueFromTheShareholder	29562195	usd
CY2022	agba	Transaction Costs In Related To Business Combination TransactionCostsInRelatedToBusinessCombination	8308754	usd
CY2022	agba	Liability Assumed Related To Forward Share Purchase Agreement LiabilityAssumedRelatedToForwardSharePurchaseAgreement	13491606	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1861223	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6449876	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	16816842	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	44844196	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	18678065	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	51294072	usd
CY2021Q2	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	187000000	usd
CY2021Q2	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	135000000	gbp
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top"> <td style="width: 0in"></td><td style="width: 0.5in">●</td><td style="text-align: justify">Use of Estimates and Assumptions</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the years presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property and equipment, impairment of long-lived assets, allowance for expected credit losses, notes receivable, share-based compensation, warrant liabilities, forward share purchase liability, provision for contingent liabilities, revenue recognition, leases, income tax provision, deferred taxes and uncertain tax position, and allocation of expenses from the holding company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The inputs into the management’s judgments and estimates consider the geopolitical tension, inflationary and high interest rate environment and other macroeconomic factors on the Company’s critical and significant accounting estimates. Actual results could differ from these estimates.</p>
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	1077184	usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	16509	usd
CY2023Q4	us-gaap	Deposits Deposits	14833	usd
CY2023	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	157190	usd
CY2023	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	50068936	usd
CY2023	agba	Recurring Asset Management Service Fees RecurringAssetManagementServiceFees	3963061	usd
CY2023	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	54189187	usd
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	176175	usd
CY2022	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	26561691	usd
CY2022	agba	Recurring Asset Management Service Fees RecurringAssetManagementServiceFees	4342361	usd
CY2022	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	31080227	usd
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.05	pure
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	3846	usd
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	30000	hkd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.50	pure
CY2023	us-gaap	Business Acquisition Planned Restructuring Activities Description BusinessAcquisitionPlannedRestructuringActivitiesDescription	- Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc.
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	595	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	2443593	usd
CY2022Q4	agba	Forward Share Purchase Liability ForwardSharePurchaseLiability	13491606	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4548	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	13496154	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-49206019	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-42282159	usd
CY2023Q4	agba	Working Capital Deficit WorkingCapitalDeficit	22221171	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65601152	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1861223	usd
CY2023Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	50000000	usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5128960	usd
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1850310	usd
CY2023	agba	Public And Private Rights PublicAndPrivateRights	4825000	shares
CY2023	agba	Shares Reserved SharesReserved	1665000	shares
CY2023	agba	Holdback Shares Percentage HoldbackSharesPercentage	0.03	pure
CY2023Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	58376985	shares
CY2023Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	58376985	shares
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	0.45
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.15
CY2022Q4	agba	Reduction Price ReductionPrice	0.1
CY2023Q2	us-gaap	Investment Sold Not Yet Purchased Balance Shares InvestmentSoldNotYetPurchasedBalanceShares	1191016	shares
CY2023Q4	us-gaap	Investment Sold Not Yet Purchased Balance Shares InvestmentSoldNotYetPurchasedBalanceShares	124949	shares
CY2023Q3	agba	Invesment Open Market At A Price Range InvesmentOpenMarketAtAPriceRange	2
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	1500000	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-378895	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	3283118	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2916609	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	312482	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	94447	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	4064861	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	3094708	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	94447	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	94576	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	217475	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	560	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-129	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	312482	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	94447	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	217475	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	1604302	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	40100	usd
CY2023Q4	agba	Allowance For Expected Credit Losses AllowanceForExpectedCreditLosses	1225	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	1673525	usd
CY2023Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.08	pure
CY2023Q4	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	589086	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	557003	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	34665	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	69581	usd
CY2023Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	25723869	usd
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	34589767	usd
CY2023Q4	us-gaap	Assets Under Management Carrying Amount AssetsUnderManagementCarryingAmount	25724464	usd
CY2022Q4	us-gaap	Assets Under Management Carrying Amount AssetsUnderManagementCarryingAmount	37033360	usd
CY2023	agba	Percentage Of Long Term Investments PercentageOfLongTermInvestments	0.00001	pure
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	1543543	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	595	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	2443593	usd
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	9.15
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.46
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount	37347329	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount	27254600	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount	6209357	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount	6209357	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-31137972	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-21045243	usd
CY2023	agba	Unrealized Gainloss From The Changes In Fair Value Investment C UnrealizedGainlossFromTheChangesInFairValueInvestmentC	272	usd
CY2022	agba	Unrealized Gainloss From The Changes In Fair Value Investment C UnrealizedGainlossFromTheChangesInFairValueInvestmentC	-5330652	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	1543543	usd
CY2023	us-gaap	Dividend Income Operating DividendIncomeOperating	1670045	usd
CY2022	us-gaap	Dividend Income Operating DividendIncomeOperating	1154749	usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	-6878869	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	-8937431	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2277832	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8168144	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	556548	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	808728	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1721284	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7359416	usd
CY2023	us-gaap	Depreciation Depreciation	261323	usd
CY2022	us-gaap	Depreciation Depreciation	392873	usd
CY2023	us-gaap	Asset Acquisition Consideration Transferred Other Assets AssetAcquisitionConsiderationTransferredOtherAssets	6130000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	664816	usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1804950	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	4477254	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	5000000	usd
CY2023Q4	agba	Short Term Borrowing ShortTermBorrowing	6804950	usd
CY2022Q4	agba	Short Term Borrowing ShortTermBorrowing	4477254	usd
CY2022Q3	us-gaap	Other Loans Payable OtherLoansPayable	4457104	usd
CY2022Q3	us-gaap	Other Loans Payable OtherLoansPayable	34800000	hkd
CY2023Q1	us-gaap	Other Loans Payable OtherLoansPayable	1793001	usd
CY2023Q1	us-gaap	Other Loans Payable OtherLoansPayable	14000000	hkd
	us-gaap	Interest Expense Other Short Term Borrowings InterestExpenseOtherShortTermBorrowings	5000000000000	usd
CY2023Q4	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.12	pure
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-378895	usd
CY2023	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	82182	usd
CY2023Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P3Y
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	482500	shares
CY2023Q4	agba	Rightofuse Asset Gross RightofuseAssetGross	12512585	usd
CY2023Q4	agba	Operating Lease Accumulated Depreciation OperatingLeaseAccumulatedDepreciation	1004432	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11508153	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1229329	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10646053	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	11875382	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1496286	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0658	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y5M1D
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1942181	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1942181	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2676638	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3201250	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	3201250	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1333854	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14297354	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2421972	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	11875382	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	225000	shares
CY2023	agba	Issuance Of Warrants IssuanceOfWarrants	528660	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	agba	Holdback Shares Percentage HoldbackSharesPercentage	0.03	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1665000	shares
CY2023Q4	agba	Stock Issued During Period Shares Issuance Of Ordinary Shares For Commitment Feein Shares StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesForCommitmentFeeinShares	600000	shares
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4900000	usd
CY2023Q4	agba	Offering Price Per Share OfferingPricePerShare	0.7
CY2023Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1850310	usd
CY2023Q4	agba	Stock Issued During Period Shares Issuance Of Ordinary Shares For Private Placementin Shares StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesForPrivatePlacementinShares	2643300	shares
CY2023Q4	agba	Warrants To Purchase Ordinary Shares WarrantsToPurchaseOrdinaryShares	528660	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1
CY2023Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	1430000	usd
CY2023	agba	Number Of Shares Issued Per Unit NumberOfSharesIssuedPerUnit	1	shares
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	16.5
CY2023	agba	Trading Days TradingDays	P30D
CY2023Q4	agba	Warrants Issued WarrantsIssued	528660	shares
CY2023	agba	Forgiveness Of Amount Due To Shareholder ForgivenessOfAmountDueToShareholder	12593384	usd
CY2022	agba	Forgiveness Of Amount Due To Shareholder ForgivenessOfAmountDueToShareholder	6000000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1856732	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y8M1D
CY2023	us-gaap	Noninterest Expense Commission Expense NoninterestExpenseCommissionExpense	37287519	usd
CY2022	us-gaap	Noninterest Expense Commission Expense NoninterestExpenseCommissionExpense	18823458	usd
CY2022Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	3600000	usd
CY2023	agba	Personnel And Benefit Expenses PersonnelAndBenefitExpenses	27217822	usd
CY2022	agba	Personnel And Benefit Expenses PersonnelAndBenefitExpenses	21928504	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	13601274	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1265866	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	9467146	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	4905636	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-49206019	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44520635	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65265397	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56084858	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.79
CY2023	agba	Percentage Of Holdback Shares PercentageOfHoldbackShares	0.03	pure
CY2022	agba	Percentage Of Holdback Shares PercentageOfHoldbackShares	0.03	pure
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11517672	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12436100	shares
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	332275	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	118073	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-45737	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6532	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	286538	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	124605	usd
CY2023	us-gaap	Results Of Operations Income Before Income Taxes ResultsOfOperationsIncomeBeforeIncomeTaxes	-48919481	usd
CY2022	us-gaap	Results Of Operations Income Before Income Taxes ResultsOfOperationsIncomeBeforeIncomeTaxes	-44396030	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.165	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.165	pure
CY2023	us-gaap	Income Tax Effects Allocated Directly To Equity Other IncomeTaxEffectsAllocatedDirectlyToEquityOther	-8071714	usd
CY2022	us-gaap	Income Tax Effects Allocated Directly To Equity Other IncomeTaxEffectsAllocatedDirectlyToEquityOther	-7325345	usd
CY2023	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	-2563028	usd
CY2022	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	-71468	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1853779	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	344640	usd
CY2023	agba	Investment Loss InvestmentLoss	1135013	usd
CY2022	agba	Investment Loss InvestmentLoss	1474676	usd
CY2022	us-gaap	Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions	888251	usd
CY2023	agba	Under Provision Of Prior Years UnderProvisionOfPriorYears	220570	usd
CY2022	agba	Under Provision Of Prior Years UnderProvisionOfPriorYears	31284	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7732994	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4822582	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Holidays IncomeTaxReconciliationTaxHolidays	21076	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Holidays IncomeTaxReconciliationTaxHolidays	21838	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18177	usd
CY2023	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	286538	usd
CY2022	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	124605	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	45858	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	45858	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8909692	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5461370	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8909692	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5461370	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5461370	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2483436	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-3448322	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-2977934	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8909692	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5461370	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	54000000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	33100000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	pure
CY2023	agba	Amounts Due To Holding Company AmountsDueToHoldingCompany	12600000	usd
CY2022	agba	Amounts Due To Holding Company AmountsDueToHoldingCompany	6000000	usd
CY2023Q3	us-gaap	Payments For Fees PaymentsForFees	83333	usd
CY2023Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	4158963	shares
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	47000000	usd
CY2022Q1	us-gaap	Shares Issued SharesIssued	1	shares
CY2023	agba	Revenue Outstanding Receivable Percentage RevenueOutstandingReceivablePercentage	0.10	pure
CY2022	agba	Revenue Outstanding Receivable Percentage RevenueOutstandingReceivablePercentage	0.10	pure
CY2023	agba	Deposit Protection Board Pays Compensation DepositProtectionBoardPaysCompensation	500000	hkd
CY2023	agba	Deposit Protection Board Pays Compensation DepositProtectionBoardPaysCompensation	64050	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1900000	usd
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit	16800000	usd
CY2023Q4	us-gaap	Foreign Financial Institutions Actual Deposits ForeignFinancialInstitutionsActualDeposits	18200000	usd
CY2023	agba	Combined Loans Receivables Percentage CombinedLoansReceivablesPercentage	0.10	pure
CY2022	agba	Combined Loans Receivables Percentage CombinedLoansReceivablesPercentage	0.10	pure
CY2019Q2	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	2000000	usd
CY2019Q2	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	17100000	hkd
CY2020Q4	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	1670000	usd
CY2020Q4	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	13000000	hkd
CY2021Q4	us-gaap	Loss Contingency Receivable LossContingencyReceivable	840000	usd
CY2023Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	1383424	usd
CY2023Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	10799560	hkd
CY2023Q4	us-gaap	Other Commitment OtherCommitment	1084439	usd
CY2023Q4	agba	Ownership Interest OwnershipInterest	1	pure
CY2023Q4	us-gaap	Cash Cash	2500000	sgd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q4	us-gaap	Cash Cash	1882000	usd
CY2023Q3	agba	Compliance Trading Per Share ComplianceTradingPerShare	1
CY2023Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	30	pure
CY2024Q1	agba	Compliance Trading Per Share ComplianceTradingPerShare	1
CY2023Q3	agba	Consecutively Trading Per Share ConsecutivelyTradingPerShare	1
CY2023Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	35000000	usd
CY2023Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	10	pure
CY2024Q1	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	2150000	usd
CY2024Q1	us-gaap	Shares Issued SharesIssued	1900000	shares
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable		usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	agba	Legal And Professional Fees Related Party LegalAndProfessionalFeesRelatedParty		usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.79
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023	us-gaap	Stock Granted During Period Value Sharebased Compensation Forfeited StockGrantedDuringPeriodValueSharebasedCompensationForfeited		usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2022	agba	Reversal Of Annual Bonus Accrued In Prior Year ReversalOfAnnualBonusAccruedInPriorYear		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
CY2022	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2022	agba	Payment To Settlement Of Forward Share Purchase Agreement PaymentToSettlementOfForwardSharePurchaseAgreement		usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
CY2023	agba	Cash Proceeds From Reverse Recapitalization Net Of Redemption CashProceedsFromReverseRecapitalizationNetOfRedemption		usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023	agba	Issue Of Ordinary Shares To Settle Payables IssueOfOrdinarySharesToSettlePayables		usd
CY2023	agba	Purchase Of Property And Equipment Through Earnest Deposit PurchaseOfPropertyAndEquipmentThroughEarnestDeposit		usd
CY2023	agba	Special Dividend To The Shareholder Offset With Amount Due From The Shareholder SpecialDividendToTheShareholderOffsetWithAmountDueFromTheShareholder		usd
CY2023	agba	Transaction Costs In Related To Business Combination TransactionCostsInRelatedToBusinessCombination		usd
CY2023	agba	Liability Assumed Related To Forward Share Purchase Agreement LiabilityAssumedRelatedToForwardSharePurchaseAgreement		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022Q4	agba	Allowance For Expected Credit Losses AllowanceForExpectedCreditLosses		usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments		usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
CY2022	agba	Legal And Professional Fees Related Party LegalAndProfessionalFeesRelatedParty		usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56084858	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65265397	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.79
CY2023	us-gaap	Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions		usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation		usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001769624

Files In Submission

Name	View Source	Status
0001213900-24-027225-index-headers.html	Edgar Link	pending
0001213900-24-027225-index.html	Edgar Link	pending
0001213900-24-027225.txt	Edgar Link	pending
0001213900-24-027225-xbrl.zip	Edgar Link	pending
agba-20231231.xsd	Edgar Link	pending
agba-20231231_cal.xml	Edgar Link	unprocessable
agba-20231231_def.xml	Edgar Link	unprocessable
agba-20231231_pre.xml	Edgar Link	unprocessable
agba-20231231_lab.xml	Edgar Link	unprocessable
ea0202484-10k_agba.htm	Edgar Link	pending
ea020248401ex21-1_agba.htm	Edgar Link	pending
ea020248401ex23-1_agba.htm	Edgar Link	pending
ea020248401ex26_agba.htm	Edgar Link	pending
ea020248401ex31-1_agba.htm	Edgar Link	pending
ea020248401ex31-2_agba.htm	Edgar Link	pending
ea020248401ex32-1_agba.htm	Edgar Link	pending
ea020248401ex32-2_agba.htm	Edgar Link	pending
ea020248401ex97-1_agba.htm	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
ex23-1_002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
ea0202484-10k_agba_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ILLR
Triller Group Inc. Stock $illr

2024 Q1 Form 10-K Financial Statement

#000121390024027225 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILLR Triller Group Inc. Stock $illr

2024 Q1 Form 10-K Financial Statement

#000121390024027225 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILLR
Triller Group Inc. Stock $illr